Literature DB >> 12736802

Immunoglobulin KM genes in Guillain-Barré syndrome.

Janardan P Pandey1, Christian A Vedeler.   

Abstract

Guillain-Barré syndrome is associated with antecedent Campylobacter jejuni infection. Only a minority of the infected individuals, however, develops the disease, implying a role for genetic factors in conferring susceptibility. To determine the role of immunoglobulin KM genes (genetic markers of the constant region of kappa chains) in the etiology of this syndrome, we genotyped 83 patients and 196 healthy controls from Norway for KM1 and KM3 alleles by polymerase chain reaction-restriction fragment length polymorphism. The frequency of KM3 homozygotes was significantly increased in patients compared with controls (86.7% vs. 74%, P=0.01, odds ratio=2.3). Conversely, the frequency of KM1/KM3 heterozygotes was significantly decreased in patients compared with controls (13.3% vs. 26%, P=0.01, odds ratio=0.4). These results suggest that KM genes may be relevant to the etiology of Guillain-Barré syndrome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736802     DOI: 10.1007/s10048-003-0144-1

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  27 in total

1.  Correlation of the Km(1) immunoglobulin allotype with anti-polysaccharide antibodies in Caucasian adults.

Authors:  D M Ambrosino; V A Barrus; G G DeLange; G R Siber
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

2.  Variable domain-identical antibodies exhibit IgG subclass-related differences in affinity and kinetic constants as determined by surface plasmon resonance.

Authors:  L J Cooper; D Robertson; R Granzow; N S Greenspan
Journal:  Mol Immunol       Date:  1994-06       Impact factor: 4.407

Review 3.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

4.  Immunoglobulin kappa chain allotypes (KM) in onchocerciasis.

Authors:  J P Pandey; L H Elson; S E Sutherland; R H Guderian; E Araujo; T B Nutman
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 5.  Advances in human immunoglobulin allotypes.

Authors:  R Grubb
Journal:  Exp Clin Immunogenet       Date:  1995

6.  Campylobacter enteritis in immune-deficient patients.

Authors:  D J Ahnen; W R Brown
Journal:  Ann Intern Med       Date:  1982-02       Impact factor: 25.391

Review 7.  Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: a review.

Authors:  J M Dugoujon; A Cambon-Thomsen
Journal:  Autoimmunity       Date:  1995       Impact factor: 2.815

8.  Role of heavy chain constant domains in antibody-antigen interaction. Apparent specificity differences among streptococcal IgG antibodies expressing identical variable domains.

Authors:  L J Cooper; A R Shikhman; D D Glass; D Kangisser; M W Cunningham; N S Greenspan
Journal:  J Immunol       Date:  1993-03-15       Impact factor: 5.422

9.  Polymerase chain reaction-based genotyping for allotypic markers of immunoglobulin kappa shows allelic association of Km with kappa variable segment.

Authors:  G Moxley; R S Gibbs
Journal:  Genomics       Date:  1992-05       Impact factor: 5.736

10.  Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and Meningococcus polysaccharides.

Authors:  J P Pandey; H H Fudenberg; G Virella; C U Kyong; C B Loadholt; R M Galbraith; E C Gotschlich; J C Parke
Journal:  Lancet       Date:  1979-01-27       Impact factor: 79.321

View more
  4 in total

1.  Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection.

Authors:  Paolo Muratori; Susan E Sutherland; Luigi Muratori; Alessandro Granito; Marcello Guidi; Georges Pappas; Marco Lenzi; Francesco B Bianchi; Janardan P Pandey
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  Immunoglobulin KM allotypes are associated with the prevalence of autoantibodies to GD1a ganglioside, but not with susceptibility to the disease, in Japanese patients with Guillain-Barré syndrome.

Authors:  Janardan P Pandey; Michiaki Koga; Nobuhiro Yuki
Journal:  Neurogenetics       Date:  2005-10-29       Impact factor: 2.660

3.  Familial Guillain-Barré syndrome: First Indian report.

Authors:  Karkal Ravishankar Naik; Aralikatte Onkarappa Saroja; Basangouda P Patil
Journal:  Ann Indian Acad Neurol       Date:  2012-01       Impact factor: 1.383

Review 4.  Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barré syndrome.

Authors:  Kishan Kumar Nyati; Kashi Nath Prasad
Journal:  Mediators Inflamm       Date:  2014-09-22       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.